The Japanese Association of Cancer Immunology (JACI), in collaboration with the Society for Immunotherapy of Cancer (SITC), is hosting their 29th JACI Annual Meeting on July 24th-26th, 2025, at WINC AICH in Nagoya, Japan.
The three-day hybrid program will feature keynote lectures from leaders in the field of IO as well as three symposiums focused on treatment of solid tumors with genetically modified immune cells, cutting-edge technologies in spatial analysis and single-cell omics analysis, and antibody-based cancer therapies. SITC has nominated a number of speakers to participate in this program as shown below.
d
SITC Speakers
Advancing CAR T Cell Therapy for Brain Tumors
- Giedre Krenciute, PhD, St. Jude Children's Research Hospital
Challenges and opportunities for CAR T cells in solid tumors
- Carl June, MD, University of Pennsylvania Perelman School of Medicine, Abramson Cancer Center
Integrated single-cell and spatial analysis of immune cell interactions in response to immune checkpoint blockade
- Athena Golfinos-Owens, PhD, Johns Hopkins University School of Medicine
Treatment of Cancer with anti-CD47/ CD40 antibodies
- Juan C. Osorio, MD, Memorial Sloan Kettering Cancer Center
d
Learn more about the program agenda here.